BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36732501)

  • 21. RNA Splicing by the Spliceosome.
    Wilkinson ME; Charenton C; Nagai K
    Annu Rev Biochem; 2020 Jun; 89():359-388. PubMed ID: 31794245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recruitment of a splicing factor to the nuclear lamina for its inactivation.
    Vester K; Preußner M; Holton N; Feng S; Schultz C; Heyd F; Wahl MC
    Commun Biol; 2022 Jul; 5(1):736. PubMed ID: 35869234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional modularity of the U2 snRNP in pre-mRNA splicing.
    van der Feltz C; Hoskins AA
    Crit Rev Biochem Mol Biol; 2019 Oct; 54(5):443-465. PubMed ID: 31744343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nuclear organization of pre-mRNA splicing factors.
    Sleeman JE; Lamond AI
    Curr Opin Cell Biol; 1999 Jun; 11(3):372-7. PubMed ID: 10395556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced Methods for the Analysis of Altered Pre-mRNA Splicing in Yeast and Disease.
    Thomas HB; O'Keefe RT
    Methods Mol Biol; 2019; 2049():131-140. PubMed ID: 31602609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
    Dvinge H; Guenthoer J; Porter PL; Bradley RK
    Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Splicing-factor alterations in cancers.
    Anczuków O; Krainer AR
    RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant RNA splicing and therapeutic opportunities in cancers.
    Yamauchi H; Nishimura K; Yoshimi A
    Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A central role of Cwc25 in spliceosome dynamics during the catalytic phase of pre-mRNA splicing.
    Tseng CK; Chung CS; Chen HC; Cheng SC
    RNA; 2017 Apr; 23(4):546-556. PubMed ID: 28057857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of phenothiazine derivatives as UHM-binding inhibitors of early spliceosome assembly.
    Jagtap PKA; Kubelka T; Soni K; Will CL; Garg D; Sippel C; Kapp TG; Potukuchi HK; Schorpp K; Hadian K; Kessler H; Lührmann R; Hausch F; Bach T; Sattler M
    Nat Commun; 2020 Nov; 11(1):5621. PubMed ID: 33159082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blocking late stages of splicing quickly limits pre-spliceosome assembly in vivo.
    Mendoza-Ochoa GI; Barrass JD; Maudlin IE; Beggs JD
    RNA Biol; 2019 Dec; 16(12):1775-1784. PubMed ID: 31671032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-mRNA splicing in the new millennium.
    Hastings ML; Krainer AR
    Curr Opin Cell Biol; 2001 Jun; 13(3):302-9. PubMed ID: 11343900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splicing to Keep Cycling: The Importance of Pre-mRNA Splicing during the Cell Cycle.
    Petasny M; Bentata M; Pawellek A; Baker M; Kay G; Salton M
    Trends Genet; 2021 Mar; 37(3):266-278. PubMed ID: 32950269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of proteins associated with splicing factors Ntr1, Ntr2, Brr2 and Gpl1 in the fission yeast
    Cipakova I; Jurcik M; Rubintova V; Borbova M; Mikolaskova B; Jurcik J; Bellova J; Barath P; Gregan J; Cipak L
    Cell Cycle; 2019 Jul; 18(14):1532-1536. PubMed ID: 31219728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Output of Protein-Coding Genes Shifts to Circular RNAs When the Pre-mRNA Processing Machinery Is Limiting.
    Liang D; Tatomer DC; Luo Z; Wu H; Yang L; Chen LL; Cherry S; Wilusz JE
    Mol Cell; 2017 Dec; 68(5):940-954.e3. PubMed ID: 29174924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural dynamics of the N-terminal domain and the Switch loop of Prp8 during spliceosome assembly and activation.
    Jia X; Sun C
    Nucleic Acids Res; 2018 May; 46(8):3833-3840. PubMed ID: 29635373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel splicing factor, Yju2, is associated with NTC and acts after Prp2 in promoting the first catalytic reaction of pre-mRNA splicing.
    Liu YC; Chen HC; Wu NY; Cheng SC
    Mol Cell Biol; 2007 Aug; 27(15):5403-13. PubMed ID: 17515604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations.
    Urrutia S; Li Z; Almanza E; Bataller A; Kanagal-Shamanna R; Senapati J; Sasaki K; Chien K; Montalban-Bravo G; DiNardo C; Borthakur G; Bueso-Ramos C; Pierce S; Kantarjian H; Garcia-Manero G
    Leukemia; 2023 Jun; 37(6):1397-1400. PubMed ID: 37185307
    [No Abstract]   [Full Text] [Related]  

  • 39. The nuts and bolts of the endogenous spliceosome.
    Sperling R
    Wiley Interdiscip Rev RNA; 2017 Jan; 8(1):. PubMed ID: 27465259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The splicing factor Prp17 interacts with the U2, U5 and U6 snRNPs and associates with the spliceosome pre- and post-catalysis.
    Sapra AK; Khandelia P; Vijayraghavan U
    Biochem J; 2008 Dec; 416(3):365-74. PubMed ID: 18691155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.